Human Coronavirus OC43 as a Low-Risk Model to Study COVID-19

Area of Science:

• Virology
• Immunology
• Epidemiology

Background:

• The COVID-19 pandemic highlighted the need for better understanding of coronavirus biology.
• Studying SARS-CoV-2 requires high-level biosafety containment (BSL-3).
• Human coronavirus OC43 (HCoV-OC43) presents a lower-risk alternative for coronavirus research.

Purpose of the Study:

• To review the biology of HCoV-OC43 as a research model.
• To discuss its application in developing COVID-19 therapeutics.
• To provide a guide for using HCoV-OC43 in low-risk settings.

Main Methods:

• Literature review of HCoV-OC43 history, classification, and clinical manifestations.
• Analysis of viral genome, genes, and evolutionary processes.
• Discussion of host factors and immunological responses to HCoV-OC43.

Main Results:

• HCoV-OC43 shares biological characteristics with other coronaviruses, making it a relevant model.
• In vitro and in vivo systems for studying HCoV-OC43 have been developed.
• HCoV-OC43 models facilitate the discovery of potential antivirals for SARS-CoV-2.

Conclusions:

• HCoV-OC43 is a valuable tool for coronavirus research in accessible laboratory settings.
• Understanding HCoV-OC43 contributes to pandemic preparedness.
• This review serves as a resource for researchers utilizing HCoV-OC43 for antiviral development.